Morpoline-bridged indazole derivatives

The present invention relates to novel morpholine-bridged indazole derivatives having the formula which stimulate soluble guanylate cyclase, to a process for the preparation thereof, and to pharmaceutical compositions containing them. These compounds are useful for the treatment of disorders of the...

Full description

Saved in:
Bibliographic Details
Main Authors LUITHLE JOACHIM, WUNDER FRANK, SCHENKE THOMAS, SCHREIBER RUDY, WIRTZ STEPHAN-NICHOLAS, LANG DIETER, KOENIG GERHARD, STASCH JOHANNES-PETER, FEURER ACHIM, STAHL ELKE
Format Patent
LanguageEnglish
Published 23.09.2008
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel morpholine-bridged indazole derivatives having the formula which stimulate soluble guanylate cyclase, to a process for the preparation thereof, and to pharmaceutical compositions containing them. These compounds are useful for the treatment of disorders of the central nervous system.
Bibliography:Application Number: US20050528601